Search
A new technology shows great promise for imaging and treating advanced forms of prostate cancer.
Memorial Sloan Kettering researchers have developed innovative ways to study some skin diseases, including melanoma skin cancer.
Sloan Kettering Institute Director Dr. Joan Massagué talks about our updated understanding of cancer metastasis.
Hyperpolarized MRI could allow doctors to get a read on a tumor’s response to treatment quickly.
Abbreviated breast magnetic resonance imaging is a cost-effective screening tool that should be made available to patients with an average lifetime risk of breast cancer, according to our recent review of protocols.
Danny Khalil, MD, PhD, medical oncologist and immunotherapy specialist at Memorial Sloan Kettering Cancer Center (MSK), has won a 2025 Scholar-Innovator Award from the Harrington Discovery Institute.
Genetic sequencing of prostate tumors can identify men who should receive immunotherapy drugs.
This form of cell death is called ferroptosis, and certain cancer cells are especially vulnerable to it.
In a recently published paper MSK's Jun Mao explores the global challenges of cancer control and the current status of integrative oncology, offering recommendations to improve access to safe, effective, evidence-based, and culturally sensitive cancer care.